Rebastinib
Rebastinib, also known as DCC-2036, is an orally bioavailable small molecule inhibitor of multiple tyrosine kinases with potential anti-tumor activity.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0504 |
| Pricing | 5.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, inquire |